Scientific publications

Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration

Jul 1, 2005 | Magazine: American Journal of Ophthalmology

Salinas-Alamán A, García-Layana A, Maldonado MJ, Sainz-Gómez C, Alvárez-Vidal A.
Department of Ophthalmology, University Clinic, University of Navarra, Pamplona, Spain.

To evaluate the role of optical coherence tomography (OCT) in determining choroidal neovascularization (CNV) activity before and after photodynamic therapy (PDT) in patients with age-related macular degeneration (ARMD).

Prospective observational case series.

Institutional study. patient population: Fifty-three patients (62 eyes) with ARMD.

Prospective observational case study.

Presence or absence of leakage on fluorescein angiography, presence of intraretinal or sub-retinal fluid on OCT, and macular and choroidal neovascular complex thickness on OCT. RESULTS: The macular thickness decreased significantly after PDT (P = .001). However, no significant changes in CNV thickness were measured after PDT (P = .567). Once the diagnosis of ARMD was established before treatment, OCT had a sensitivity of 96.77% for detecting CNV activity. After treatment, OCT had a good sensitivity (95.65%) and a moderate specificity (59.01%) in determining CNV activity, which resulted in a diagnostic efficiency (proportion of correct results) of 82.95%.

OCT appears to be useful for indicating CNV activity. Therefore, it may serve as a complementary technique for deciding the need for PDT and re-treatment in patients with ARMD.

CITATION  Am J Ophthalmol. 2005 Jul;140(1):23-8